Home » Analyst Articles – US
Nike (NKE) Research Coverage Started at Buckingham Research
Analysts at Buckingham Research began coverage on shares of Nike (NYSE:NKE) in a report released on Saturday. The brokerage set a “buy” rating and a $72.00 price target on the footwear maker’s stock. Buckingham Research’s... More of this article »
Foot Locker (FL) Raised to “Buy” at Buckingham Research
Foot Locker (NYSE:FL) was upgraded by research analysts at Buckingham Research from a “neutral” rating to a “buy” rating in a research report issued on Friday, Marketbeat reports. The firm currently has a $57.00... More of this article »
PriceSmart (PSMT) Downgraded by Scotiabank to Hold
PriceSmart (NASDAQ:PSMT) was downgraded by analysts at Scotiabank to a “hold” rating in a research report issued on Friday. They currently have a $90.00 price target on the stock. Scotiabank’s price objective would... More of this article »
Howard Weil Downgrades PriceSmart (PSMT) to Sector Perform
PriceSmart (NASDAQ:PSMT) was downgraded by equities researchers at Howard Weil from a “sector outperform” rating to a “sector perform” rating in a note issued to investors on Friday. Several other equities analysts... More of this article »
Neurocrine Biosciences (NBIX) PT Raised to $105.00
Neurocrine Biosciences (NASDAQ:NBIX) had its price objective boosted by equities researchers at Jefferies Group to $105.00 in a note issued to investors on Friday, The Fly reports. The brokerage presently has a “buy” rating... More of this article »
Constellation Brands (STZ) PT Raised to $250.00
Constellation Brands (NYSE:STZ) had its price target upped by equities researchers at Evercore ISI from $235.00 to $250.00 in a research report issued on Friday. The firm currently has an “outperform” rating on the stock.... More of this article »
Nomura (NMR) Rating Increased to Overweight at JPMorgan Chase & Co.
Nomura (NYSE:NMR) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Friday. Separately, Zacks Investment... More of this article »
Antero Midstream GP (AMGP) Rating Increased to Buy at Goldman Sachs Group
Antero Midstream GP (NYSE:AMGP) was upgraded by equities research analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday, Marketbeat reports.... More of this article »
SemGroup (SEMG) Downgraded by Goldman Sachs Group to “Neutral”
SemGroup (NYSE:SEMG) was downgraded by investment analysts at Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Friday, MarketBeat Ratings... More of this article »
Juno Therapeutics (JUNO) Now Covered by Analysts at Needham & Company LLC
Research analysts at Needham & Company LLC initiated coverage on shares of Juno Therapeutics (NASDAQ:JUNO) in a research note issued to investors on Friday, Marketbeat.com reports. The brokerage set a “buy” rating... More of this article »
Antero Midstream Partners (AM) Research Coverage Started at Credit Suisse Group
Investment analysts at Credit Suisse Group assumed coverage on shares of Antero Midstream Partners (NYSE:AM) in a research report issued on Friday, Marketbeat reports. The firm set an “outperform” rating and a $35.00 price... More of this article »
Valeant Pharmaceuticals Intl (VRX) Given New $27.00 Price Target at TD Securities
Valeant Pharmaceuticals Intl (NYSE:VRX) (TSE:VRX) had its price objective raised by stock analysts at TD Securities from $20.00 to $27.00 in a research note issued to investors on Friday. The firm currently has a “buy”... More of this article »
Comerica (CMA) Upgraded to “Buy” at Instinet
Comerica (NYSE:CMA) was upgraded by investment analysts at Instinet from a “neutral” rating to a “buy” rating in a note issued to investors on Friday. A number of other brokerages have also issued reports on... More of this article »
Comerica (CMA) Upgraded by Nomura to “Buy”
Comerica (NYSE:CMA) was upgraded by investment analysts at Nomura from a “neutral” rating to a “buy” rating in a report released on Friday, MarketBeat reports. The brokerage currently has a $106.00 price objective... More of this article »
Illumina (ILMN) Cut to Market Perform at William Blair
Illumina (NASDAQ:ILMN) was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating in a research note issued to investors on Friday, Marketbeat reports. A number of other... More of this article »
EQT Midstream Partners (EQM) Earns Neutral Rating from Analysts at Credit Suisse Group
Credit Suisse Group assumed coverage on shares of EQT Midstream Partners (NYSE:EQM) in a research note issued to investors on Friday, MarketBeat reports. The brokerage set a “neutral” rating and a $71.00 price target on... More of this article »
Ironwood Pharmaceuticals (IRWD) Downgraded by Bank of America
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by research analysts at Bank of America from a “buy” rating to an “underperform” rating in a research report issued on Friday, MarketBeat.com reports. They... More of this article »
EnLink Midstream Partners (ENLK) Receives New Coverage from Analysts at Credit Suisse Group
Investment analysts at Credit Suisse Group began coverage on shares of EnLink Midstream Partners (NYSE:ENLK) in a note issued to investors on Friday, MarketBeat Ratings reports. The firm set a “neutral” rating and a $16.00... More of this article »
Cerner (CERN) Price Target Raised to $83.00
Cerner (NASDAQ:CERN) had its target price increased by investment analysts at Cantor Fitzgerald to $83.00 in a note issued to investors on Friday. The brokerage currently has an “overweight” rating on the stock. Cantor... More of this article »
Oppenheimer Raises United Therapeutics (UTHR) Price Target to $180.00
United Therapeutics (NASDAQ:UTHR) had its target price hoisted by analysts at Oppenheimer to $180.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on... More of this article »
GrubHub (GRUB) Price Target Increased to $80.00 by Analysts at Oppenheimer
GrubHub (NYSE:GRUB) had its target price boosted by stock analysts at Oppenheimer to $80.00 in a research report issued on Friday. The firm presently has an “outperform” rating on the information services provider’s... More of this article »
Aptiv (APTV) Now Covered by Analysts at Longbow Research
Equities research analysts at Longbow Research began coverage on shares of Aptiv (NYSE:APTV) in a research report issued to clients and investors on Friday, MarketBeat.com reports. The firm set a “buy” rating and a $105.00... More of this article »
Longbow Research Begins Coverage on Autoliv (ALV)
Investment analysts at Longbow Research initiated coverage on shares of Autoliv (NYSE:ALV) in a report issued on Friday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $155.00 price target on the auto... More of this article »